Kurt Graves
CIK 1406337 · EVP, Chief Commercial Officer · last filed 2026-07-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$29.66M
Companies
5
Total Filings
58
Lifetime Open-Market Net
-$5.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MCRB | Director | — | $4.80 | — | $0 | 14 | 2026-07-10 |
| Radius Health, Inc. (RDUS) Delisted | Director | 11,000 | $30.00 | $330.0K | -$4.97M | 14 | 2020-02-24 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Director | 0 | — | — | $0 | 9 | 2020-01-29 |
| PULM | Director | — | $1.68 | — | $0 | 3 | 2016-02-25 |
| VRTX | EVP, Chief Commercial Officer | 60,485 | $490.39 | $29.66M | -$496.4K | 17 | 2009-10-21 |
Recent Filings · Page 2 of 6
58 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-29 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Disp (D) | −22,709 | -$143.1K | EDGAR |
| 2019-06-14 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2019-04-18 | Radius Health, Inc. (RDUS) Delisted | Sell (S) | −4,800 | -$107.1K | EDGAR |
| 2019-02-26 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | +5,500 | $0 | EDGAR |
| 2019-02-13 | Radius Health, Inc. (RDUS) Delisted | Exer (M) | +4,800 | $0 | EDGAR |
| 2019-01-25 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-27 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2018-02-15 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-13 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-21 | MCRB | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.